Unblinded Results from a dose-escalating placebo-controlled study with allogeneic bone marrow-derived mesenchymal stem cells for the treatment of refractory perianal fistulas in patients with Crohn's disease

Autor:	Molendijk, I., Bonsing, B. A., Roelofs, H., Peeters, K. C., martin wasser, Veenendaal, R. A., Zwaginga, J. J., Verspaget, H. W., Fibbe, W. E., Meulen-De Jong, A. E., Hommes, D. W.
Jazyk:	angličtina
Rok vydání:	2015
Zdroj:	Journal of Crohn's and Colitis, 9, S254-S255 Web of Science
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::88d98308e165ec0fa1f53e9f5123585b https://hdl.handle.net/1887/106583 Zobrazit plný text záznamu